Apogee Therapeutics, Inc. · NASDAQ:APGE

Henderson Michael Thomas sold 20,000 Apogee Therapeutics, Inc. shares (Form 4)

Traded Jun 10, 2026 · Filed Jun 12, 2026

On Jun 10, 2026, Henderson Michael Thomas (Director, Chief Executive Officer) sold 20,000 Apogee Therapeutics, Inc. shares at an average US$83.38 for US$1.67M under a trading plan, leaving 1,095,987 shares. Filed Jun 12, 2026 (Form 4).

Sold
20,000 shares
Price
US$83.38 average (US$82.21 to US$86.89)
Value
US$1.67M
Holding after
1,095,987 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 10, 2026Common StockSale6,770US$82.211,109,217Direct
Jun 10, 2026Common StockSale7,654US$82.781,101,563Direct
Jun 10, 2026Common StockSale1,080US$84.181,100,483Direct
Jun 10, 2026Common StockSale1,577US$85.191,098,906Direct
Jun 10, 2026Common StockSale2,305US$86.271,096,601Direct
Jun 10, 2026Common StockSale614US$86.891,095,987Direct

Source

View original at SEC

Related